Results 271 to 280 of about 162,477 (300)

Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF‐κB Signaling Pathway in LPS‐Induced ARDS

The FASEB Journal, Volume 39, Issue 21, 15 November 2025.
ORM1 promotes LPS‐induced ARDS by activating NF‐κB in alveolar epithelial II cells, upregulating TF/PAI‐1 to cause hypercoagulation and fibrinolysis inhibition, leading to lung injury. ORM1 knockdown reverses these effects, indicating therapeutic potential.
Xianjun Chen, Ying Liu, Song Mu, Tingting Chen, Jia Yuan, Chuan Xiao, Qi Dong, Qing Li, Ying Wang, Qimin Chen, Shuwen Li, Wei Li, Feng Shen   +12 more
wiley   +1 more source

Diagnostic value of tissue plasminogen activator-inhibitor complex in sepsis-induced liver injury: A single-center retrospective case-control study. [PDF]

World J Hepatol
Zhou Y, He LP, Qi YH, Huang Y, Hu BQ, Liu JL, Zeng QB, Song JC.   +7 more
europepmc   +1 more source

Droplet-based microfluidics and engineering of tissue plasminogen activator for biomedical applications

, 2009
Lucia Granieri
openalex   +1 more source

Mechanical Tricuspid Valve Thrombosis Successfully Treated With Tissue Plasminogen Activator. [PDF]

JACC Case Rep
Haraf R, Atkinson T, Elizabeth Le DT, Arora B.   +3 more
europepmc   +1 more source

Successful Treatment of Central Retinal Artery Occlusion With Tissue Plasminogen Activator Followed by Recurrent Retinal Ischemia. [PDF]

J Vitreoretin Dis
Hsu J, Brown J, Mallick A, Fara M, De Leacy R, Rosen RB, Ginsburg RN, Lema GMC.   +7 more
europepmc   +1 more source

The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion. [PDF]

Biophys J
Bannish BE, Paynter B, Risman RA, Shroff M, Tutwiler V.   +4 more
europepmc   +1 more source

Cerebral arterial collateral status, but not venous outflow profiles, modifies the effect of intravenous tissue plasminogen activator in acute ischemic stroke. [PDF]

Brain Circ
Gencer ES, Yilmaz E, Arsava EM, Gocmen R, Topcuoglu MA.   +4 more
europepmc   +1 more source

Clot-Targeted Nanogels for Dual-Delivery of AntithrombinIII and Tissue Plasminogen Activator to Mitigate Disseminated Intravascular Coagulation Complications. [PDF]

ACS Nano
Sheridan A, Nellenbach K, Pandit S, Byrnes E, Hardy G, Lutz H, Moiseiwitsch N, Scull G, Mihalko E, Levy JH, Brown AC.   +10 more
europepmc   +1 more source

Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer. [PDF]

BMC Biotechnol
Ji Y, Qin Y, Tan Q, Qiu Y, Han S, Qi X.
europepmc   +1 more source